- Published at
- by smallcaps.com.au
positive
positive
Memphasys pilot study confirms RoXsta’s potential as high-throughput antioxidant diagnostic tool
A pilot study has shown that Memphasys’ (ASX: MEM) RoXsta Mega Cell high-throughput assay device can conduct large-scale, simultaneous antioxidant assays